# Quality Improvement PrecivityAD Clinician Survey (QUIP I)

> **NCT05477056** · — · COMPLETED · sponsor: **C2N Diagnostics** · enrollment: 366 (actual)

## Conditions studied

- Alzheimer Disease
- Mild Cognitive Impairment
- Dementia
- Cognitive Decline

## Interventions

- **OTHER:** PrecivityAD blood test

## Key facts

- **NCT ID:** NCT05477056
- **Lead sponsor:** C2N Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-01
- **Primary completion:** 2022-10-06
- **Final completion:** 2022-10-06
- **Target enrollment:** 366 (ACTUAL)
- **Last updated:** 2025-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05477056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05477056, "Quality Improvement PrecivityAD Clinician Survey (QUIP I)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05477056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*